First comparison of common breast cancer tests finds varied accuracy of predictions
Commercially-available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence...
List view / Grid view
Commercially-available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence...
Scientists have developed a new optical imaging system that uses red and near-infrared light to identify breast cancer patients who will respond to chemotherapy...
Bursting oxygen-filled microbubbles in breast cancer makes tumours three times more sensitive to radiation therapy in preliminary tests with animal models of the disease...
The FDA has expanded the approved use of Lynparza to include the treatment of patients with metastatic breast cancer who have a BRCA gene mutation...
A new study suggests breast cancer patients taking palbociclib/letrozole combination therapy should avoid foods rich in xenoestrogens...
Kisqali receives breakthrough therapy designation for initial endocrine-based treatment of pre- or perimenopausal women with HR+/HER2- advanced or metastatic breast cancer...
Researchers have developed tiny drug-laden nanoparticles that can seek and destroy cancer stem cells...
NICE recommends Kisqali as a cost-effective treatment option for postmenopausal women within England and Wales with advanced breast cancer...
In vitro study verifies method for remotely triggering release of cancer drugs...
Patients with advanced breast cancer who are treated with a combination of drugs are at increased risk of suffering adverse side effects...
Researchers find novel combination disrupts multiple factors in aggressive breast cancer...
Investigational therapy directly kills tumour cells and unmasks them to the body's defences.
Pregnancy-associated breast cancer, which is rare but often aggressive, has been detected with MRI...
Mvasi, a biosimilar to the cancer drug Avastin, is approved for certain colorectal, lung, brain, kidney and cervical cancers…
According to results of the LORELEI clinical trial, adding taselisib to letrozole before surgery significantly improved outcomes for patients with early breast cancer...